Brief: Mirati Therapeutics Announces Pricing Of Upsized Public Offering of 9.67 Mln Shares At A Price To Public Of $27.80 Per Share
09/08/2023 05:39
Aug 9 (Reuters) - Mirati Therapeutics Inc MRTX.O :
* MIRATI THERAPEUTICS ANNOUNCES PRICING OF UPSIZED PUBLIC
OFFERING
* MIRATI THERAPEUTICS INC- PRICING OF AN UNDERWRITTEN PUBLIC
OFFERING OF 9.67 MILLION SHARES OF ITS COMMON STOCK AT A PRICE
TO PUBLIC OF $27.80 PER SHARE
Source text for Eikon: ID:nPn93NKja
Further company coverage: MRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mirati Therapeutics
See all newsBrief: European Commission Approves KRAZATI As A Targeted Treatment For Non-Small Cell Lung Cancer
US FDA turns down Amgen lung cancer drug Lumakras for full approval (updated)
US FDA turns down Amgen lung cancer drug Lumakras for full approval
Brief: Mirati Stockholders Voted 'For' Proposal To Adopt Deal Between Co, Bristol-Myers Squibb
Mirati's lung cancer drug gets EU's regulatory backing (updated)